Lidocaine/Prilocaine Medicated Plaster

利多卡因/丙胺卡因膏药贴

Report date: 2025/02/25 10:01:42

Base Information

Drug NameLidocaine/Prilocaine Medicated Plaster
Drug Alias NameLidocaine and Prilocaine Medicated Plaster利丙双卡因膏药贴Prilocaine/Lidocaine Medicated Plaster丙胺卡因/利多卡因膏药贴Lidocaine/Prilocaine Medicated Plaster +[15] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunitVoltage-gated calcium channel
Therapy Area/IndicationsPainAnesthesia
Global Approved IndicationsPainAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryDenmark
Original Approved Date1993/03/03
Country/TerritoryDenmarkEUMainland China +[4] 
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca AsSato Pharmaceutical LtdOrifarm Generics As +[4] 
Inactive CompaniesN/A
Active IndicationsPainAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A